$28.85
-6.9%HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
HTFL • NASDAQ
| Heartflow, Inc. Common Stock Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
OPERATING ACTIVITIES | |||
-116.8M | -96.4M | -95.7M | |
8.6M | 8.1M | 7.6M | |
14M | 10.2M | 11.9M | |
47.9M | 20M | 8.3M | |
(0.0) | (0.0) | (405K) | |
-7.7M | -10.9M | -8.5M | |
-54M | -69M | -76.4M | |
INVESTING ACTIVITIES | |||
-5M | -4.4M | -6.1M | |
-233.5M | (0.0) | (0.0) | |
-238.6M | -4.4M | -6.1M | |
FINANCING ACTIVITIES | |||
408.5M | 0.0 | -228K | |
-121.9M | 0.0 | 0.0 | |
(0.0) | (0.0) | -228K | |
-510K | 2.2M | 589K | |
286M | 2.2M | 169.3M | |
CASH FLOW SUMMARY | |||
-193K | -271K | -504K | |
-6.7M | -71.4M | 86.3M | |
51.5M | 127.2M | 41M | |
44.8M | 55.8M | 127.2M | |
-59M | -73.4M | -82.5M |
HTFL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 14, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 14, 2026 | May 14, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 18, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 18, 2026 | March 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 12, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 12, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | September 19, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 10, 2025 | September 10, 2025 | 2025 |
Continue your HTFL research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.